Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,581 to 1,600 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer. | J Clin Med | 2020 | 32498288 | PubTator, text mining | PubMed |
Impact of CD56 Continuously Recognizable as Prognostic Value of Acute Promyelocytic Leukemia: Results of Multivariate Analyses in the Japan Adult Leukemia Study Group (JALSG)-APL204 Study and a Review of the Literature. | Cancers (Basel) | 2020 | 32492981 | PubTator, text mining | PubMed |
| Acute Myeloid Leukemia iPSCs Reveal a Role for RUNX1 in the Maintenance of Human Leukemia Stem Cells. | Cell Rep | 2020 | 32492433 | PubTator, text mining | PubMed |
| Prognostic significance of Spinster homolog gene family in acute myeloid leukemia. | J Cancer | 2020 | 32489475 | PubTator, text mining | PubMed |
| Six Candidate miRNAs Associated With Early Relapse in Pediatric B-Cell Acute Lymphoblastic Leukemia. | Anticancer Res | 2020 | 32487609 | PubTator, text mining | PubMed |
| DNA Methylation Changes in Human Papillomavirus-Driven Head and Neck Cancers. | Cells | 2020 | 32486347 | PubTator, text mining | PubMed |
| Molecular Landscape of Acute Myeloid Leukemia: Prognostic and Therapeutic Implications. | Curr Oncol Rep | 2020 | 32476069 | PubTator, text mining | PubMed |
| Additional gene mutations may refine the 2017 European LeukemiaNet classification in adult patients with de novo acute myeloid leukemia aged <60 years. | Leukemia | 2020 | 32461631 | PubTator, text mining | PubMed |
| Expression of RUNX1-ETO Rapidly Alters the Chromatin Landscape and Growth of Early Human Myeloid Precursor Cells. | Cell Rep | 2020 | 32460028 | PubTator, text mining | PubMed |
| Sequencing-Based Measurable Residual Disease Testing in Acute Myeloid Leukemia. | Front Cell Dev Biol | 2020 | 32457898 | PubTator, text mining | PubMed |
| Gain of chromosome 21 in hematological malignancies: lessons from studying leukemia in children with Down syndrome. | Leukemia | 2020 | 32433508 | PubTator, text mining | PubMed |
| Histone Deacetylases (HDACs): Evolution, Specificity, Role in Transcriptional Complexes, and Pharmacological Actionability. | Genes (Basel) | 2020 | 32429325 | PubTator, text mining | PubMed |
| Defined lifestyle and germline factors predispose Asian populations to gastric cancer. | Sci Adv | 2020 | 32426482 | PubTator, text mining | PubMed |
| FGviewer: an online visualization tool for functional features of human fusion genes. | Nucleic Acids Res | 2020 | 32421816 | PubTator, text mining | PubMed |
| Clinical and immunological features of platelet transfusion refractoriness in young patients with de novo acute myeloid leukemia. | Cancer Med | 2020 | 32419364 | PubTator, text mining | PubMed |
| Dysregulated haematopoietic stem cell behaviour in myeloid leukaemogenesis. | Nat Rev Cancer | 2020 | 32415283 | PubTator, text mining | PubMed |
| ULK1 inhibition as a targeted therapeutic strategy for FLT3-ITD-mutated acute myeloid leukemia. | J Exp Clin Cancer Res | 2020 | 32393312 | PubTator, text mining | PubMed |
| Allogeneic hematopoietic stem cell transplantation at the first remission for younger adults with FLT3-internal tandem duplication AML: The JALSG AML209-FLT3-SCT study. | Cancer Sci | 2020 | 32391628 | PubTator, text mining | PubMed |
| Systematic Construction and Validation of a Metabolic Risk Model for Prognostic Prediction in Acute Myelogenous Leukemia. | Front Oncol | 2020 | 32373530 | PubTator, text mining | PubMed |
| NARASIMHA: Novel Assay based on Targeted RNA Sequencing to Identify ChiMeric Gene Fusions in Hematological Malignancies. | Blood Cancer J | 2020 | 32372024 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=80